Clicky

Genomictree Inc.(228760)

Description: Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.


Keywords: Biotechnology Cancer Infectious Diseases Molecular Biology Lung Cancer Colorectal Cancer Biomarkers Molecular Diagnostics Laboratory Techniques Bladder Cancer Polymerase Chain Reaction Real Time Polymerase Chain Reaction Molecular Diagnostic Products Hematuria

Home Page: genomictree.com

44-6 Techno 10-ro
Daejeon, 34027
South Korea
Phone: 82 4 2861 4551


Officers

Name Title
Dr. Sung-Whan An CEO & President
Hong Sun Lee Head of Management Support Headquarters & CFO
Mr. Chi-Wang Yoon COO & VP
Dr. Tae-Jeong Oh Ph.D. Head of R&D Division
Un Lee Yong Executive Director of Commercial Operations
Soon Kim Myung Head of Molecular Diagnostic Lab

Exchange: KQ

Country: KR : Korea (Republic of)

Currency: Korean Won (₩)

GIC Sector: Energy
GIC Group: Energy
GIC Industry: Oil, Gas & Consumable Fuels
GIC Sub-Industry: Coal & Consumable Fuels
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.9338
Price-to-Sales TTM: 231.8566
IPO Date:
Fiscal Year End: December
Full Time Employees: 81
Back to stocks